UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

The lancet. Diabetes & endocrinology, 2014-11, Vol.2 (11), p.901-910

Yki-Järvinen, Hannele, Prof

2014

Volltextzugriff (PDF)

Dietary carbohydrates and fats in nonalcoholic fatty liver disease

Nature reviews. Gastroenterology & hepatology, 2021-11, Vol.18 (11), p.770-786

2021

Volltextzugriff (PDF)

Diagnosis of non-alcoholic fatty liver disease (NAFLD)

Diabetologia, 2016-06, Vol.59 (6), p.1104-1111

Yki-Järvinen, Hannele

2016

Volltextzugriff (PDF)

Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling

PloS one, 2020-01, Vol.15 (1), p.e0227285-e0227285

2020

Volltextzugriff (PDF)

Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance

Nutrients, 2015-11, Vol.7 (11), p.9127-9138

Yki-Järvinen, Hannele

2015

Volltextzugriff (PDF)

Fatty liver: a novel component of the metabolic syndrome

Arteriosclerosis, thrombosis, and vascular biology, 2008-01, Vol.28 (1), p.27-38

2008

Volltextzugriff (PDF)

Ceramides: A Cause of Insulin Resistance in Nonalcoholic Fatty Liver Disease in Both Murine Models and Humans

Hepatology (Baltimore, Md.), 2020-04, Vol.71 (4), p.1499-1501

2020

Volltextzugriff (PDF)

Increased Liver Fat, Impaired Insulin Clearance, and Hepatic and Adipose Tissue Insulin Resistance in Type 2 Diabetes

Gastroenterology (New York, N.Y. 1943), 2008-07, Vol.135 (1), p.122-130

2008

Volltextzugriff (PDF)

Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease

Proceedings of the National Academy of Sciences - PNAS, 2020-03, Vol.117 (13), p.7347-7354

2020

Volltextzugriff (PDF)

Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors

Gastroenterology (New York, N.Y. 1943), 2009-09, Vol.137 (3), p.865-872

2009

Volltextzugriff (PDF)

Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic Review

International journal of molecular sciences, 2016-04, Vol.17 (5), p.633-633

2016

Volltextzugriff (PDF)

LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover

Gut, 2021-01, Vol.70 (1), p.180-193

2021

Volltextzugriff (PDF)

Genes Involved in Fatty Acid Partitioning and Binding, Lipolysis, Monocyte/Macrophage Recruitment, and Inflammation Are Overexpressed in the Human Fatty Liver of Insulin-Resistant Subjects

Diabetes (New York, N.Y.), 2007-11, Vol.56 (11), p.2759-2765

2007

Volltextzugriff (PDF)

Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease

Journal of hepatology, 2022-03, Vol.76 (3), p.526-535

2022

Volltextzugriff (PDF)

The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans

Journal of hepatology, 2016-12, Vol.65 (6), p.1263-1265

2016

Volltextzugriff (PDF)

Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans

The American journal of clinical nutrition, 2012-10, Vol.96 (4), p.727-734

2012

Volltextzugriff (PDF)

Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1‐year patient‐level meta‐analysis of the EDITION clinical studies in people with type 2 diabetes

Diabetes, obesity & metabolism, 2018-03, Vol.20 (3), p.541-548

2018

Volltextzugriff (PDF)

Comparison of Basal Insulin Added to Oral Agents Versus Twice-Daily Premixed Insulin as Initial Insulin Therapy for Type 2 Diabetes

Diabetes care, 2005-02, Vol.28 (2), p.254-259

2005

Volltextzugriff (PDF)

From the metabolic syndrome to NAFLD or vice versa ?

Digestive and liver disease, 2010-05, Vol.42 (5), p.320-330

2010

Volltextzugriff (PDF)

Why does obesity cause diabetes?

Cell metabolism, 2022-01, Vol.34 (1), p.11-20

2022

Volltextzugriff (PDF)

Diabetes, Liver Cancer, and Cirrhosis: What Next?

Hepatology (Baltimore, Md.), 2018-10, Vol.68 (4), p.1220-1222

2018

Volltextzugriff (PDF)

Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease

Nature communications, 2016-02, Vol.7 (1), p.8994-9, Article 8994

2016

Volltextzugriff (PDF)

Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study

Diabetologia, 2017-10, Vol.60 (10), p.1873-1882

2017

Volltextzugriff (PDF)

Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease

The Journal of clinical investigation, 2022-11, Vol.132 (21), p.1-8

2022

Volltextzugriff (PDF)

Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver

Diabetes (New York, N.Y.), 2009-01, Vol.58 (1), p.203-208

2009

Volltextzugriff (PDF)

1 – 25 von 459

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(438)
Mit Volltextzugriff
(390)

Publikationsform

Sprache

Englisch
(458)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(308)
Science & Technology
(300)
Life Sciences & Biomedicine
(285)
Male
(208)
Adult
(183)
Biological And Medical Sciences
(168)
Female
(166)
Middle Aged
(145)
Medical Sciences
(141)
Endocrinology & Metabolism
(135)
Insulin Resistance
(99)
Insulin
(86)
Diabetes
(69)
Endocrinopathies
(69)
Obesity
(63)
Endocrine Pancreas. Apud Cells
(59)
Liver - Metabolism
(59)
Diabetes. Impaired Glucose Tolerance
(58)
Insulin - Blood
(57)
Blood Glucose - Metabolism
(55)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

Dietary carbohydrates and fats in nonalcoholic fatty liver disease

Diagnosis of non-alcoholic fatty liver disease (NAFLD)

Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling

Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance

Fatty liver: a novel component of the metabolic syndrome

Ceramides: A Cause of Insulin Resistance in Nonalcoholic Fatty Liver Disease in Both Murine Models and Humans

Increased Liver Fat, Impaired Insulin Clearance, and Hepatic and Adipose Tissue Insulin Resistance in Type 2 Diabetes

Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease

Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors

Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic Review

LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover

Genes Involved in Fatty Acid Partitioning and Binding, Lipolysis, Monocyte/Macrophage Recruitment, and Inflammation Are Overexpressed in the Human Fatty Liver of Insulin-Resistant Subjects

Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease

The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans

Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans

Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1‐year patient‐level meta‐analysis of the EDITION clinical studies in people with type 2 diabetes

Comparison of Basal Insulin Added to Oral Agents Versus Twice-Daily Premixed Insulin as Initial Insulin Therapy for Type 2 Diabetes

From the metabolic syndrome to NAFLD or vice versa ?

Why does obesity cause diabetes?

Diabetes, Liver Cancer, and Cirrhosis: What Next?

Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease

Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study

Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease

Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver

Suchergebnisse filtern